Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

499
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chainsaw culture: Cladophialophora bantiana cerebral abscess after chainsaw activity in an immunocompetent host. Illustrative case.

Journal of neurosurgery. Case lessons·2026
Same author

Utility of dynamic <sup>18</sup>F-fluoroethyl-L-tyrosine positron emission tomography in determining pseudoprogression from tumor recurrence in the 6 months following radiation therapy for glioblastoma.

Neuro-oncology advances·2026
Same author

Glioblastoma mimicking anti-NMDA receptor encephalitis: a case series.

Internal medicine journal·2026
Same author

Real-world safety and effectiveness of ofatumumab in multiple sclerosis: A clinic-based study in Australia.

Multiple sclerosis journal - experimental, translational and clinical·2026
Same author

A Study of Time to Recovery Following Loss of Neuromonitoring Signal of the Recurrent Laryngeal Nerve in Thyroid Surgery.

World journal of surgery·2026
Same author

Safety and efficacy of B-cell therapy in older people with multiple sclerosis.

Frontiers in immunology·2026
Same journal

The paradox of peer review: protecting science or policing thought?

Internal medicine journal·2026
Same journal

Immune-related pancytopenia in pregnancy.

Internal medicine journal·2026
Same journal

Crossover effect: causal machine learning reveals opposing mortality responses to mean arterial pressure targets among phenotypically distinct hypertensive patients with septic shock.

Internal medicine journal·2026
Same journal

Clinicopathological findings, correlations and outcomes in patients with renal disease and living with antiretroviral-treated human immunodeficiency virus infection.

Internal medicine journal·2026
Same journal

Approach to thyroid disorders associated with immune checkpoint inhibitors and tyrosine kinase inhibitors.

Internal medicine journal·2026
Same journal

A scoping review of specialist hypertension clinics.

Internal medicine journal·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

8.9K

Advancements in multiple sclerosis.

Turlough Montague1, James Drummond2, Karl Ng1,3

  • 1Department of Neurology, Royal North Shore Hospital, Sydney, New South Wales, Australia.

Internal Medicine Journal
|April 2, 2025
PubMed
Summary
This summary is machine-generated.

Multiple sclerosis (MS) management is advancing with updated diagnostic criteria and novel biomarkers for earlier intervention. Innovative therapies like CAR T-cell therapy and Epstein-Barr virus (EBV) vaccination offer new hope for progressive MS patients.

Keywords:
MRImultiple sclerosisneuroimmunologyneurology

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.4K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.9K

Related Experiment Videos

Last Updated: Jun 14, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

8.9K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.4K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.9K

Area of Science:

  • Neurology
  • Immunology
  • Clinical Medicine

Background:

  • Global prevalence of multiple sclerosis (MS) is rising, necessitating early diagnosis and intervention to reduce disability.
  • Current treatments effectively lower relapse rates, yet progressive and degenerative aspects of MS remain significant challenges.
  • Existing disease-modifying therapies are evolving with updated diagnostic criteria and emerging biomarkers.

Purpose of the Study:

  • To provide a comprehensive clinical perspective on multiple sclerosis.
  • To highlight recent advancements in MS diagnosis and treatment.
  • To explore innovative therapeutic directions for managing MS.

Main Methods:

  • Review of current clinical practices and diagnostic criteria for MS.
  • Analysis of emerging biomarkers for MS patient care optimization.
  • Exploration of novel therapeutic strategies, including cell-based therapies and vaccinations.

Main Results:

  • Updates to McDonald diagnostic criteria enhance sensitivity for earlier MS detection.
  • Novel biomarkers show promise for personalized MS care and treatment optimization.
  • Innovative therapies such as CAR T-cell therapy and EBV vaccination are emerging as promising future directions.

Conclusions:

  • Early diagnosis and treatment are crucial for mitigating MS-related disability.
  • Advancements in diagnostics and biomarkers are facilitating timely intervention.
  • Innovative immunotherapies represent a significant shift in the future management of multiple sclerosis.